The percentage of CD39+ monocytes is higher in pregnant COVID-19+ patients than in nonpregnant COVID-19+ patients
Author(s) -
Arturo CérbuloVázquez,
Maritza García-Espinosa,
Jesús Carlos BrionesGarduño,
Lourdes ArriagaPizano,
Eduardo FeratOsorio,
Berenice Zavala-Barrios,
Graciela Libier CabreraRivera,
Patricia Miranda-Cruz,
María Teresa García de la Rosa,
Jessica L. PrietoChávez,
Vanessa Rivero-Arredondo,
Ruth L. Madera-Sandoval,
Alonso CruzCruz,
Enrique SalazarRíos,
María E. Salazar-Rios,
David Serrano-Molina,
R. C. De Lira-Barraza,
Abel Humberto VillanuevaCompean,
Alejandra EsquivelPineda,
Rubén RamírezMontes de,
Felipe CaldiñoSoto,
Luz Angélica Ramírez-García,
Guillermo Flores,
O. MorenoAlvarez,
Guadalupe GuerreroAvendaño,
Constantino LópezMacías
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0264566
Subject(s) - immunology , chemokine , medicine , immune system , immunophenotyping , peripheral blood mononuclear cell , serology , cytokine , covid-19 , monocyte , biology , flow cytometry , antibody , disease , infectious disease (medical specialty) , biochemistry , in vitro
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom